GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 85 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,602,000 | -13.5% | 50,137 | -6.3% | 0.00% | 0.0% |
| Q1 2022 | $1,853,000 | +18.3% | 53,484 | -0.1% | 0.00% | +33.3% |
| Q4 2021 | $1,567,000 | +15.5% | 53,539 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $1,357,000 | -26.8% | 53,267 | +0.6% | 0.00% | -25.0% |
| Q2 2021 | $1,854,000 | -12.6% | 52,938 | +1.6% | 0.00% | -20.0% |
| Q1 2021 | $2,122,000 | -64.4% | 52,091 | -62.1% | 0.01% | -64.3% |
| Q4 2020 | $5,957,000 | +17.2% | 137,528 | +49.2% | 0.01% | 0.0% |
| Q3 2020 | $5,081,000 | +470.9% | 92,148 | +553.0% | 0.01% | +366.7% |
| Q2 2020 | $890,000 | +23.6% | 14,111 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $720,000 | -35.7% | 14,111 | -53.6% | 0.00% | -40.0% |
| Q1 2017 | $1,120,000 | +50.5% | 30,400 | -40.9% | 0.01% | +66.7% |
| Q4 2016 | $744,000 | -37.3% | 51,470 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $1,187,000 | +39.0% | 51,470 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $854,000 | – | 51,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |